Trials that use: Non-inferiority trial design
New to this method? Read the tutorial →
637 results
- A Trial of Two Family-based Childhood Obesity Treatment Programs: Complete Statistical AnalysisIndependent statistical analysis of A Trial of Two Family-based Childhood Obesity Treatment Programs: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03245775).
- A Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Type 1 Diabetes Subjects: Complete Statistical AnalysisIndependent statistical analysis of A Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Type 1 Diabetes Subjects: primary endpoint results, effect estimate with confidence interval,…
- A Trial to Evaluate CG5503 Efficacy and Safety in Acute Pain After Bunionectomy: Complete Statistical AnalysisIndependent statistical analysis of A Trial to Evaluate CG5503 Efficacy and Safety in Acute Pain After Bunionectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Trial to Evaluate the Efficacy, Safety & Tolerability of Brexpiprazole in the Maintenance Treatment of Adults With Major Depressive Disorder: Complete Statistical AnalysisIndependent statistical analysis of A Trial to Evaluate the Efficacy, Safety & Tolerability of Brexpiprazole in the Maintenance Treatment of Adults With Major Depressive Disorder: primary endpoint results, effect estimate with confidence…
- A Trial to Evaluate the Safety and Immunogenicity of ADACEL® Vaccine in Persons 65 Years of Age and Older: Complete Statistical AnalysisIndependent statistical analysis of A Trial to Evaluate the Safety and Immunogenicity of ADACEL® Vaccine in Persons 65 Years of Age and Older: primary endpoint results, effect estimate with confidence interval, sample-size…
- A-TREATIndependent statistical analysis of American Trial Using Tranexamic Acid in Thrombocytopenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02578901).
- ABATEIndependent statistical analysis of Active Bathing to Eliminate Infection (ABATE Infection) Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02063867).
- Absorb IV Randomized Controlled Trial: Complete Statistical AnalysisIndependent statistical analysis of Absorb IV Randomized Controlled Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02173379).
- Accent CardiacIndependent statistical analysis of Accent Cardiac MRI Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02041702).
- ACCESSIndependent statistical analysis of Adductor Canal Catheter Effectiveness and Safety Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04639128).
- ACCOASTIndependent statistical analysis of A Comparison of Prasugrel at PCI or Time of Diagnosis of Non-ST Elevation Myocardial Infarction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Accupressure of P6 to Reduce Nausea During Cesarean Section: Complete Statistical AnalysisIndependent statistical analysis of Accupressure of P6 to Reduce Nausea During Cesarean Section: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04799587).
- ACCURATEIndependent statistical analysis of A Safety and Effectiveness Trial of Spinal Cord Stimulation of the Dorsal Root Ganglion for Chronic Lower Limb Pain: primary endpoint results, effect estimate with confidence interval, sample-size…
- Acetazolamide Efficacy in Ataxia in PMM2-CDG: Complete Statistical AnalysisIndependent statistical analysis of Acetazolamide Efficacy in Ataxia in PMM2-CDG: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04679389).
- ACHIEVE-HIFUIndependent statistical analysis of ACHIEVE Hearing Intervention Follow-Up Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05070429).
- ACT IIndependent statistical analysis of Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects Who Are at Standard Risk for Carotid Endarterectomy With Significant Extracranial Carotid Stenotic Disease (ACT I): primary endpoint results,…
- Acupuncture With Manual and Electrical Stimulation to Reduce Labour Pain: Complete Statistical AnalysisIndependent statistical analysis of Acupuncture With Manual and Electrical Stimulation to Reduce Labour Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01197950).
- Acute and Residual Effects of Caffeinated Beer: Complete Statistical AnalysisIndependent statistical analysis of Acute and Residual Effects of Caffeinated Beer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00515294).
- Acute Low Back Pain. Topical Diclofenac and Oral Ibuprofen.: Complete Statistical AnalysisIndependent statistical analysis of Acute Low Back Pain. Topical Diclofenac and Oral Ibuprofen.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04611529).
- Ad26.COV2.SIndependent statistical analysis of the phase 3 Ad26.COV2.S trial in healthy adults for COVID-19 prevention, including randomized design, influenza and SARS-CoV-2 immunogenicity endpoints, ANOVA, geometric mean ratios, non-inferiority, confidence intervals, and safety.
- ADAPTIndependent statistical analysis of ADAPT: Addressing Depression and Pain Together: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01124188).
- Addressing Social Determinants of Health & Diabetes Self-Management in Vulnerable Populations: Complete Statistical AnalysisIndependent statistical analysis of Addressing Social Determinants of Health & Diabetes Self-Management in Vulnerable Populations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Adefovir Dipivoxil In Compensated Chronic Hepatitis B Patients: Complete Statistical AnalysisIndependent statistical analysis of Adefovir Dipivoxil In Compensated Chronic Hepatitis B Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00316719).
- Adipose-derived SVF for the Treatment of Knee OA: Complete Statistical AnalysisIndependent statistical analysis of Adipose-derived SVF for the Treatment of Knee OA: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02726945).
- ADJUNCT ONE™Complete statistical analysis of the phase 3 ADJUNCT ONE™ trial of liraglutide as adjunct therapy to insulin in type 1 diabetes, including non-inferiority analysis of HbA1c, body-weight and insulin-dose results, hypoglycemia, methodology,…
- AEGEANIndependent statistical analysis of Assessment of an Education and Guidance Programme for Eliquis Adherence in Non-Valvular Atrial Fibrillation (AEGEAN): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- AFFILIATEIndependent statistical analysis of Effects of Oral Sildenafil on Mortality in Adults With PAH: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02060487).
- Aggressive Fever Control With Intravenous Ibuprofen After Non-traumatic Brain Hemorrhage: Complete Statistical AnalysisIndependent statistical analysis of Aggressive Fever Control With Intravenous Ibuprofen After Non-traumatic Brain Hemorrhage: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01530880).
- AHAvsSIMIndependent statistical analysis of A Trial to Compare American Heart Association (AHA) and Simple (SIM)Method to Give Adenosine to Treat Supra-ventricular Tachycardia (SVT): primary endpoint results, effect estimate with confidence interval, sample-size…
- AiME – 13Independent statistical analysis of A Phase 3 Study Comparing the Effects of Subcutaneous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance…
- Air-Q® SP Versus Air-Q® and I-gel: A Randomized Clinical Trial: Complete Statistical AnalysisIndependent statistical analysis of Air-Q® SP Versus Air-Q® and I-gel: A Randomized Clinical Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01592760).
- Alemtuzumab + Rituximab Consolidation in CLL: Complete Statistical AnalysisIndependent statistical analysis of Alemtuzumab + Rituximab Consolidation in CLL: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00771602).
- Alkali Therapy in Chronic Kidney Disease: Complete Statistical AnalysisIndependent statistical analysis of Alkali Therapy in Chronic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01452412).
- Alkaline Water in Reducing Skin Toxicity in Women With Breast Cancer Undergoing Radiation Therapy: Complete Statistical AnalysisIndependent statistical analysis of Alkaline Water in Reducing Skin Toxicity in Women With Breast Cancer Undergoing Radiation Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Allogeneic HCT With HLA-matched Donors : a Phase II Randomized Study Comparing 2 Nonmyeloablative Conditionings: Complete Statistical AnalysisIndependent statistical analysis of Allogeneic HCT With HLA-matched Donors : a Phase II Randomized Study Comparing 2 Nonmyeloablative Conditionings: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- ALTA-3Independent statistical analysis of A Study of Brigatinib Compared to Alectinib in Adults With Non-Small-Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Amlodipine Versus Nifedipine ER for the Management of Postpartum Hypertension: Complete Statistical AnalysisIndependent statistical analysis of Amlodipine Versus Nifedipine ER for the Management of Postpartum Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04790279).
- Amoxicillin Versus Benzyl Penicillin for Treatment of Children Hospitalised With Severe Pneumonia: Complete Statistical AnalysisIndependent statistical analysis of Amoxicillin Versus Benzyl Penicillin for Treatment of Children Hospitalised With Severe Pneumonia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- AMPLITUDE-OIndependent statistical analysis of the phase 3 AMPLITUDE-O trial of efpeglenatide in people with type 2 diabetes, including randomized design, time-to-event endpoints, non-inferiority and superiority analyses, hazard ratios, confidence intervals, and statistical…
- An Efficacy and Safety Study of Fixed-dose Rosiglitazone/Glimepiride to Treat Chinese Type 2 Diabetes Patients: Complete Statistical AnalysisIndependent statistical analysis of An Efficacy and Safety Study of Fixed-dose Rosiglitazone/Glimepiride to Treat Chinese Type 2 Diabetes Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- An Efficacy and Tolerability Study of Topiramate in Participants With Migraine: Complete Statistical AnalysisIndependent statistical analysis of An Efficacy and Tolerability Study of Topiramate in Participants With Migraine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- An Evaluation of Protective Effects of OpalSeal™ Against Early Dental Decay in Orthodontic Patients: Complete Statistical AnalysisIndependent statistical analysis of An Evaluation of Protective Effects of OpalSeal™ Against Early Dental Decay in Orthodontic Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- An Extension Study of LAQ/5062 Exploring the Long Term Safety, Tolerability and Clinical Effect Parameters During the Disease: Complete Statistical AnalysisIndependent statistical analysis of An Extension Study of LAQ/5062 Exploring the Long Term Safety, Tolerability and Clinical Effect Parameters During the Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- An Innovative Conversational Agent (Quitbot) for Smoking Cessation: Complete Statistical AnalysisIndependent statistical analysis of An Innovative Conversational Agent (Quitbot) for Smoking Cessation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04308759).
- An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (0431-024): Complete Statistical AnalysisIndependent statistical analysis of An Investigational Drug Study in Patients With Type 2 Diabetes Mellitus (0431-024): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- An Open Label Safety and Tolerability Study of AIN457 in Patients With Moderate to Severe Crohn’s Disease: Complete Statistical AnalysisIndependent statistical analysis of An Open Label Safety and Tolerability Study of AIN457 in Patients With Moderate to Severe Crohn's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- An Open-Label, Randomized, Phase 3 Trial of Nivolumab Versus Investigator’s Choice Chemotherapy as First-Line Therapy for Stage IV or Recurrent PD-L1+ Non-Small Cell Lung Cancer (CheckMate 026): Complete Statistical AnalysisIndependent statistical analysis of An Open-Label, Randomized, Phase 3 Trial of Nivolumab Versus Investigator's Choice Chemotherapy as First-Line Therapy for Stage IV or Recurrent PD-L1+ Non-Small Cell Lung Cancer (CheckMate 026): primary…
- Antibiotics Usage in Pediatric Orthopaedic Percutaneous Surgery (APOPS): Complete Statistical AnalysisIndependent statistical analysis of Antibiotics Usage in Pediatric Orthopaedic Percutaneous Surgery (APOPS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03261830).
- Antidepressant Effects of TS-161 in Treatment-Resistant Depression: Complete Statistical AnalysisIndependent statistical analysis of Antidepressant Effects of TS-161 in Treatment-Resistant Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04821271).
- Antimicrobial Barrier Dressing Versus Closed-incision Negative Pressure Therapy in the Obese Primary Total Joint Arthroplasty: Complete Statistical AnalysisIndependent statistical analysis of Antimicrobial Barrier Dressing Versus Closed-incision Negative Pressure Therapy in the Obese Primary Total Joint Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…